Aijex Pharma International Inc. (API) is a Japanese Corporation primarily focused on needle-free jet injection technology apart from other specialty products.
Aijex Pharma International Inc., Japan (API) was established in June 2016 in co-operation with HNS International Inc., USA. API is currently located at Toyama Prefecture, Japan with offices in the USA & Germany.
API is now focused on further research & development of the needle-free technology with the aim of bringing it to a larger section of the society.
R&D is underway and nearing successful completion at Japan to introduce pre-fil ampoules with disposable injectors suitable for pharmaceutical formulations requiring subcutaneous injections like interferon, growth hormones etc. Pharmaceutical drug manufacturers are invited to tie-up with API for bringing this innovation to the market.